Xie Chengrun: Navigating Industry Cycles Requires More Than Internal Efforts - It Demands a Decade of Deep Collaboration

Deep News
7小时前

Addressing the 2026 Yabuli Forum Summer Annual Meeting held in Chengdu, Sichuan from September 4-6, Xie Chengrun, Chief Executive Officer of Sino Biopharmaceutical Limited and Chairman of Chia Tai Tianqing and Beijing Tide, delivered a keynote speech. He stated that 2026 marks a year of significant breakthroughs for China's biopharmaceutical sector, representing a period of explosive growth following five years of accumulated groundwork.

Xie emphasized that economic cycles should not be viewed as periods of decline or crisis, but rather as the natural rhythm of systematic self-repair and rebalancing that presents opportunities. He stressed that engaging in industry development during a downturn is the optimal starting point, which is why he has dedicated the past five years to focusing on corporate management and strategic alignment. Thanks to this counter-cyclical growth capability, Sino Biopharmaceutical Limited has achieved double-digit growth in both sales and profits over the past three years.

Regarding how to navigate industry cycles, Xie pointed out that the company has established two core strategic pillars: AI adoption and international expansion. He believes AI is sparking a revolution in R&D paradigms and corporate management. Xie revealed that Sino Biopharmaceutical Limited has invested over 600 million yuan in AI infrastructure, developing six major AI-assisted platforms covering small molecules, ADC, and molecular glues, which have deeply empowered 25 early-stage R&D pipelines and 37 clinical pipelines. Currently, the company's pipeline capability ranks 14th globally, and AI has compressed Phase III clinical trial timelines for certain products to under two years, while increasing production capacity by 20% per batch in manufacturing operations.

On the internationalization front, Xie stated that 2026 serves as the inaugural year for overseas licensing deals. In March and July of this year, the company successfully completed two major overseas licensing agreements. He emphasized that the next decade will be defined by collaboration rather than the burn-rate approach of going it alone. Xie called for a shift in mindset, asserting that navigating industry cycles cannot rely solely on internal efforts but requires deep cooperation over the next ten years. He argued that in today's complex environment, the old competitive tactics of territorial expansion and winner-take-all are no longer sufficient. Instead, multi-dimensional and deep-level collaboration represents the path forward for successfully traversing industry cycles.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10